DrugPatentWatch Database Preview

Details for Patent: 5,856,529

Which drugs does patent 5,856,529 protect, and when does it expire?

Patent 5,856,529 protects HETLIOZ and is included in one NDA.

This patent has twenty-nine patent family members in twenty-four countries.

Summary for Patent: 5,856,529

Title:	Benzofuran and dihydrobenzofuran melatonergic agents
Abstract:	Novel derivatives of benzofuran and dihydrobenzofuran are provided which are useful as melatonergic agents.
Inventor(s):	Catt; John D. (Southington, CT), Johnson; Graham (Madison, CT), Keavy; Daniel J. (Killingworth, CT), Mattson; Ronald J. (Meriden, CT), Parker; Michael F. (Middletown, CT), Takaki; Katherine S. (Middletown, CT), Yevich; Joseph P. (Southington, CT)
Assignee:	Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:	08/987,478
Patent Claim Types: see list of patent claims	Compound; Use; Composition;

Drugs Protected by US Patent 5,856,529

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Vanda Pharms Inc	HETLIOZ	tasimelteon	CAPSULE;ORAL	205677-001	Jan 31, 2014		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y	Y		TREATMENT OF NON-24 HOUR SLEEP-WAKE DISORDER BY ADMINISTERING TASIMELTEON	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Non-Orange Book US Patents Family Members for Patent 5,856,529

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
5,981,571	Benzodioxa alkylene ethers as melatonergic agents	➤ Sign Up
6,060,506	Benzopyran derivatives as melatonergic agents	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Patents Family Members for US Patent 5,856,529

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Taiwan	476758	➤ Sign Up
Russian Federation	2190609	➤ Sign Up
Portugal	1027043	➤ Sign Up
Poland	190499	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 5,856,529

For more information try a trial or see the plans and pricing